North America Volume and Revenue Strength
North America volume growth of ~5.5% in Q4 and ~14% for full year; Q4 sales up ~5.8% and full-year net revenue growth in the region of ~14%, driven by strong e-commerce demand and large enterprise accounts.
Automation Revenue Momentum
Automation revenue ~ $40M in 2025 (north of $40M reported), achieving ~35% full-year growth and nearly 40% growth in the quarter on a constant currency basis. Automation broke even on an Adjusted EBITDA basis in Q4 and has a strong order book entering 2026.
Ambitious 2026 Automation Guidance
Company expects automation revenue growth of 30%–50% in 2026 (potentially > $60M) and to turn automation positive on an Adjusted EBITDA basis; reiterates longer-term objective to surpass $100M in automation revenue.
Consolidated Revenue Growth
Consolidated net revenue increased ~2.2% year-over-year in Q4 on a constant currency basis (or ~4.4% excluding warrant impacts). Full-year net revenue rose approximately 4.7%–5.0% on a constant currency basis (or ~6.1% excluding ~$5M warrant-related headwind).
Strategic Customer Partnerships
Strengthened relationships with two of the world’s largest e-commerce/retail leaders and a major collaboration with Medline for automated box customization; company expects these relationships to contribute materially over coming years (>$1B cumulative revenue opportunity over 8–10 years).
Technology and Operational Investment
Invested > $20M in cloud-native, AI-ready technology infrastructure since 2022; pursuing AI, robotics and vision systems integration that management says will enable productivity gains and cross-selling of automation.
Improved Liquidity and Disciplined CapEx
Year-end cash balance of $63M with no revolver draws; reported net leverage 4.4x LTM and stated target to reach 2.5x–3.0x within 18–24 months. FY2025 CapEx $30.3M, down from $33.1M in 2024 and down 45% vs. 2023.
2026 Financial Guidance
2026 guidance: net revenue growth 5.0%–12.7% (constant currency) and Adjusted EBITDA growth 5.4%–19.9%; implies net revenue $415M–$445M and Adjusted EBITDA $83.5M–$95M at EUR1.16 spot rate. Management also provided free cash flow expectations (~$15M at midpoint after CapEx, interest, taxes and working capital).